MedTech Spectrum

Article Name Medical Devices

Protera Health Integrates with Epic to Deliver Seamless Digital MSK Care for Health Plans and Health Systems

Integration aims to enhance care coordination, transparency, and outcomes for musculoskeletal patients through EpicCare Link.

14th August, 2025

DeepSight™ Technology Receives First FDA 510(k) Clearance for NeedleVue™ LC1 Ultrasound System

Bringing Clarity and Confidence to Ultrasound-Guided Interventional Procedures

14th August, 2025

OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer

Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device.

14th August, 2025

Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and including the Undisturbed Date, and exceeds the highest closing price as quoted on the Stock Exchange since 2022 The proposed privatisation will be effected by way of a scheme of arrangement; the Offeror Concert Parties collectively hold 74.75% shares in the Company; an Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the Proposal The Proposal presents shareholders with certainty over their ability to monetise their interests in Kangji Medical Holdings Limited, following a period of sustained pressure on trading prices and limited liquidity

13th August, 2025

Veeva Report Highlights Medtech Push for Site Collaboration & Data Quality

Survey reveals tech adoption gap despite industry focus on trial efficiency

13th August, 2025

Avant & Ainnova Refine Patient Recruitment Strategy for Vision AI Clinical Trial

Targeting diverse diabetic population to enhance early detection of diabetic retinopathy

13th August, 2025

Body Vision Medical Expands LungVision® Platform with AI Tomo® Upgrade

New feature enables compatibility with almost any fluoroscopic C-arm, advancing global lung cancer diagnostics

13th August, 2025

Myra Vision Gains FDA Approval to Begin IDE Study for Glaucoma Therapy System

Trial to assess Calibreye™ Titratable Glaucoma Therapy™ Surgical System in refractory glaucoma patients

13th August, 2025

Conformal Medical Raises $32M to Advance Next-Gen Stroke Prevention Device

Funding boost to support pivotal trial and pre-commercialization of CLAAS® AcuFORM™ LAAO system.

13th August, 2025

Dräger Atlan A350 Series Earns Highest U.S. Cybersecurity Clearance for Medical Devices

Authority to Operate (ATO) certification from the U.S. Department of Defense affirms Dräger’s leadership in safeguarding patient data, delivering a fully ATO-certified anesthesia portfolio trusted by hospitals worldwide.

12th August, 2025

Cardio Partners Announces Acquisition of RescueStat

The acquisition reinforces Sarnova's and Cardio Partners' long-term support for vendors and partners while opening new opportunities for collaboration

11th August, 2025

QinFlow Launches Advanced Fluid and Blood Warming Solution to Meet Critical Needs in ORs and ICUs

Founded in 2009, QinFlow is a market leader in fluid thermoregulation solutions.

08th August, 2025

ASP Unveils BIOTRACE™ Instant Read Steam System for Real-Time Sterility Assurance

New system empowers sterile processing departments with the fastest FDA-cleared readout on the market, enabling real-time decision-making and elevating operational efficiency.

08th August, 2025

Bracco Imaging’s SonoVue® Secures NMPA Approval for HyCoSy Use in China, Enhancing Non-Invasive Infertility Diagnostics

Regulatory milestone supports China’s reproductive health goals by enabling radiation-free, high-accuracy ultrasound imaging to assess fallopian tube patency and uterine abnormalities in women.

06th August, 2025